Accendra Health, Inc. ACH
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.88% | -195.84% | -203.47% | -2,647.58% | -2,734.35% |
| Total Depreciation and Amortization | 16.52% | -5.79% | -25.71% | -24.30% | -28.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.98% | 204.05% | 161.92% | 5,650.66% | 3,991.62% |
| Change in Net Operating Assets | 170.47% | -154.87% | 172.36% | -6,341.23% | -146.99% |
| Cash from Operations | -278.89% | -165.11% | -163.03% | -148.93% | -69.66% |
| Capital Expenditure | 25.84% | 15.81% | 13.81% | -4.72% | -12.04% |
| Sale of Property, Plant, and Equipment | 116.63% | 122.54% | -24.61% | -29.85% | -30.59% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.55% | -92.13% | -299.03% | -671.26% | -77.51% |
| Cash from Investing | 248.51% | 251.38% | 223.93% | -87.01% | -66.27% |
| Total Debt Issued | 0.20% | -9.97% | 38.69% | 153.24% | 285.42% |
| Total Debt Repaid | -1.40% | 21.93% | -15.58% | -95.03% | -201.11% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 47.07% | -477.25% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.44% | 87.07% | 77.60% | 326.45% | -237.57% |
| Cash from Financing | -33.07% | 164.16% | 170.28% | 195.20% | 54.38% |
| Foreign Exchange rate Adjustments | -96.59% | 406.95% | 310.43% | -70.18% | 696.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.64% | 231.27% | 204.06% | 83.48% | -451.11% |